This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: F. Hoffmann-La Roche Ag. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: The Innovations of Aaron Osborne
Introduction
Aaron Osborne is an accomplished inventor based in South San Francisco, CA. He has made significant contributions to the field of medical science, particularly in the treatment of eye diseases. His work focuses on innovative solutions that address critical health issues.
Latest Patents
Aaron Osborne holds a patent for the "Treatment of Age-Related Macular Degeneration and Diabetic Macular Edema by Administration of a Bispecific Antibody to VEGF and ANG-2." This patent represents a breakthrough in the treatment of serious eye conditions, showcasing his commitment to improving patient outcomes.
Career Highlights
Osborne is currently employed at F. Hoffmann-La Roche AG, a leading global healthcare company. His role at the company allows him to collaborate with other experts in the field and contribute to groundbreaking research and development.
Collaborations
Throughout his career, Aaron has worked alongside talented colleagues, including Jayashree Sahni and Robert James Weikert. These collaborations have fostered an environment of innovation and creativity, leading to advancements in medical treatments.
Conclusion
Aaron Osborne's contributions to the field of medicine through his innovative patent and collaborative efforts highlight his dedication to improving healthcare. His work continues to inspire advancements in the treatment of eye diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile